[Characterization of tofacitinib use as COVID-19 therapy]. [PDF]
Rev Colomb Reumatol, 2022 Toribio Polanco FJ +6 more
europepmc +1 more source
Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020. [PDF]
Arq Bras Cardiol, 2020 Soeiro AM +7 more
europepmc +1 more source
Variability in public procurement prices for Group 1A drugs in the specialized pharmaceutical component: an observational study, 2013-2022. [PDF]
Epidemiol Serv SaudeRossignoli P +2 more
europepmc +1 more source
Control of occult hepatitis B virus infection. [PDF]
Adv Lab Med, 2022 Lalana Garcés M +14 more
europepmc +1 more source
Insuficiencia hepática aguda secundaria a fiebre amarilla: un escenario complejo. [PDF]
Clin Liver Dis (Hoboken), 2019 Song ATW, D'Albuquerque YLAC.
europepmc +1 more source
Conocimientos básicos sobre enfermedades víricas emergentes: apuntes para atención primaria (parte 2). [PDF]
FMC, 2018 Alonso Saratxaga E, Pérez Esquerdo MR.
europepmc +1 more source
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. [PDF]
Med Intensiva, 2021 Díaz E +8 more
europepmc +1 more source
[Epidemiology of hepatitis C virus infection in ColombiaEpidemiologia da infecção pelo vírus da hepatite C na Colômbia]. [PDF]
Rev Panam Salud Publica, 2021 López-Osorio MC, Beltrán M, Navas MC.
europepmc +1 more source